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INTRODUCTION 
Rheumatoid arthritis (RA) is a systemic and chronic 
inflammatory autoimmune d isease, is characterized by 
synovial lin ing hyperplasia, chronic synovitis and 
progressive bone and cartilage damage.
1,2
 Complete 
Freund's Adjuvant (CFA) contains heat killed  
Mycobacterium in water-in-o il (paraffin oil) Emulsion. In 
Arthritis, Bone erosions representing bony destruction 
were evident on bone unprotected by cartilage. The spleen 
provided a readily available source of cells known to be 
involved in arthritis, so splenomegaly (spleen enlargement) 
is a marker for Presence of Arthrit is .
3
 
The therapies available for RA are disease-modifying anti- 
rheumatic drugs (DMARDs). The uses of DMARDs have 
of long-term side effects and toxicity, therefore their usage 
have been impeded.
4
 India is the largest and oldest 
botanical garden in world. Bambusa arundinacea is 
distributed throughout the moist parts of India. The 
Methanolic extract showed the presence of flavonoids, 
glycosides, traces of alkaloids and phytosterols, which give 
Anti-ulcer & Anti-inflammatory activity.
5
 Quite a large 
number of studies have found that different parts of 
Bambusa arundinacea possess medicinal activ ities like 
Antidiabetic activity,
6
 Antifertility effect,
7 
Antibacterial 
activity,
8
 Anti-inflammatory and Protective effects .
9  
 
MATERIALS AND METHODS  
1 Animals 
Protocol of the study was passed by Institutional Ethics 
Committee of C. U Shah College of Pharmacy and 
Research, Wadhwan. The study was carried out with adult 
female Wistar rats weighing 200–300 g. Animals were 
acclimat ized to the experimental conditions in cages and 
kept under standard environmental conditions (22 ± 3◦C; 
12/12 h light/dark cycle). Rats were allowed to feed and 
water ad lib itum. 
2 Plant materials  
The disease free fresh plant material (Leaves) was 
collected in the month of December 2011 from 
surrounding area of Ahmedabad, Gujarat and authenticated 
at Botany Department of Gujarat University by Dr. H. A. 
Solanki. After authentication, fresh leaves were collected 
in bulk from the tree, shade dried, pulverized and passed 
through sieve no.40 to obtain coarse powder. 
3 Preparation of the extract 
5
 
The Shade dried & powdered leaves (400 gm.) were 
subjected to continuous hot extraction with methanol in  
Soxhlet extractor for 48 hrs, followed by concentrating 
extract under vacuum. The extracts were stored in airt ight 
bottle until use. 
4 Phytochemical studies 
The Methanolic ext ract of Bambusa arundinacea (BA) 
was subjected to phytochemical analysis. Methanolic 
extract showed the presence of flavonoids, saponins, 
carbohydrates, and terpenoids. 
5 Induction of CFA and BA treatment 
Adult wistar female rat with an initial body weight of 200 
to 300g were taken, and div ided into six groups each 
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containing six an imals. On day zero, all rats were in jected 
into the sub plantar region of the left hind paw with 0.1ml 
of Complete Freund’s Adjuvant. This consist of 
Mycobacterium butyricum suspended in heavy paraffin oil 
by thorough grinding with motor and pestle to give a 
concentration of 6mg/ml. Dosing with the test and standard 
compounds was started on the zero day and continued for 
12 days according to the following schedule: Group I: 
Normal control (Distilled water), Group II: Disease control 
(suspension of 1% CMC), Group III: Dexamethasone (5 
mg/kg, i.p. standard), Group IV: Methanolic extract of 
Bambusa arundinacea (100 mg/kg, p.o.), Group V: 
Methanolic extract of Bambusa arundinacea (200 mg/kg, 
p.o.), Group VI: Methanolic extract of Bambusa 
arundinacea (300 mg/kg, p.o.). From day 13th to 21st, the 
animals were not dosed with the test compound or the 
standard. The following parameters were measured 
10
. 
5.1 Evaluation of the development of Arthritis  
Rats were inspected daily for the onset of arthritis 
characterized by edema in the paws. The incidence and 
severity of arthritis were evaluated using a system of 
arthritic scoring, and measurement of bi-hind paw volumes 
every 3 days beginning on the day when arthritic signs 
were first visible. Animals were observed for presence or 
absence of nodules in different organs like ear, fore paw, 
hind paw, nose and tail. Animal were score 0 for absence 
and 1 for presence of nodules. 5 was the potential 
maximum of combined arthrit ic score per animal. Hind 
paw volume was measured using plethysmometer. Paw 
volumes of both hind limbs were recorded from day of 
Treatment started to 21
st
 day at three day interval
 
using 
mercury column p lethysmometer.
11 
5.2 Rheumatoid Factor  
The latex turbid imetry method was used in the present 
study using RF turbilatex kit of SPINREACT Company. 
Calibrat ion was carried out for linear range up to 100 
IU/ml. The reading of RF factor of all the groups obtained 
was compared with the control animals and was expressed 
as IU/ml RF. 
12  
5.3 Radiography 
Female wistar rats were sacrificed on 21
st
 
 
day of CFA 
administration and legs were removed and placed on 
formalin containing plastic bags. This plastic bag was kept 
at a distance of 90 cm from the X-ray source and 
Radiographic analysis of arthritic and treated animal h ind 
paw were performed by X-ray machine with a 300-mA 
exposition for 0.01 s. An investigator blinded for the 
treatment reg imen performed rad iograph score. The 
following radiograph criteria were considered: These 
scores (destroyed or intact joint) were used as a quantal 
test for bone necrosis. Radiographs were carefully  
examined using a stereo microscope and abnormalit ies 
were graded as follows:  
(i) Periosteaic reaction, 0 - 3 (None, Slight, Moderate, 
Marked);  
(ii) Erosions, 0 - 3 (None, Few, Many Small, Many Large);  
(iii) Jo int space narrowing, 0 - 3 (None, Min imal, 
Moderate, Marked);  
(iv) Jo int space destruction, 0 - 3 (None, Min imal, 
Extensive, Ankylosis).  
Bone destruction was scored on the patella as described 
previously. 
13 
5.4 Effect on S pleen-Index 
At the end of the experiment, after sampled for serum, all 
mice were sacrificed by ether anesthesia. All the spleens of 
mice were weighed immediately after dissection. The 
spleen indexes were calcu lated by using the following 
formula: 
14 
        Spleen weight of CFA rat/ Body weight of CFA rat     
Index =   ___________________________________________ 
            Spleen weight of normal rat/Body weight of normal rat  
 
5.5 Histological Processing and Assessment of Arthritis 
Damage  
Rats were sacrificed by ether anesthesia. Knee joints were 
removed and fixed for 4 days in 4% formaldehyde. After 
decalcification in 5 % formic acid, the specimens were 
processed for paraffin embedding tissue sections (7 μm 
thick) and were stained with haematoxylin and eosin, or 
safranin. An experienced pathologist, unaware of the 
different drug treatments scored the condition of tibiotarsal 
joints. Histopathological changes were scored using the 
following parameters. Infilt ration of cells was scored on a 
scale from 0 to 3, depending on the amount of 
inflammatory cells in the synovial tissues. Inflammatory  
cells in the joint cavity were graded on a scale from 0 to 3 
and expressed as exudate. A characteristic parameter in  
arthritis is the progressive loss of articular cart ilage. Th is 
destruction was separately graded on a scale from 0 to 3, 
ranging from the appearance of dead chondrocytes (empty 
lacunae) to complete loss of the articular cartilage. Bone 
erosion was scored on a scale ranging from 0 to 3, ranging 
from no abnormalities to complete loss of cortical and 
trabecular bone of the femoral head. Cartilage and bone 
destruction by pannus formation was scored ranging from 
0, no change; 1, mild change (pannus invasion within 
cartilage); 2, moderate change (pannus invasion into 
cartilage/subchondral bone); 3, severe change (pannus 
invasion into the subchondral bone); and vascularity (0, 
almost no blood vessels; 1, a few blood vessels; 2, some 
blood vessels; 3, many blood vessels). Histopathological 
changes in the knee joints were scored in the femur reg ion 
on 5 semi-serial sections of the joint, spaced 70 μm apart. 
Scoring was performed on decoded slides by two 
observers, as described earlier.
15-18 
RES ULT & DISCUSS ION 
The hind paw injected with Complete Freund’s Adjuvant 
became gradually swollen and reached its peak at 21
st
 day. 
Figure-1 showed the results obtained for the different 
doses of BA and the standard drug (Dexamethasone 
5mg/kg) in the Complete Freund’s Adjuvant-induced 
(CFA) paw edema test at specific t ime intervals. It was 
obvious that during 21
st
 day treatment paw edema in  
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disease control inflamed paw is increase in time dependent 
manner and all administration groups significantly  
inhibited the development of joint swelling induced by 
Complete Freund’s Adjuvant. 
 
FIGURE 1:  Effect of Methanolic extract of Bambusa arundinacea on Paw Edema in Arthritic Rats  
Arthritic index and Rheumatoid factor were significantly decreased in treatment with BA (100 mg/kg, 200 mg/kg and 
300mg/kg) and Dexamethasone (5 mg/kg) treated animal as compared to disease control treatment as shown in Figure 2, 
Figure 3. 
 
FIGURE 2: Effect of Methanolic extract of Bambusa arundinacea on Arthritic index in Arthritic Rats  
 
FIGURE 3: Effect of Methanolic extract of Bambusa arundinacea on RF in Arthritic Rats 
Bone destruction, which is a common feature of adjuvant arthritis, was examined by radiological analysis. Complete 
Freund’s Adjuvant treated rats had developed definite joint space narrowing of the intertarsal joints, diffuse soft tissue 
swelling that included the digits, diffuse demineralization of bone, marked periosteal thickening, and cystic enlargement of 
bone and extensive erosions produced narrowing or pseudo widening of all joint spaces. In contrast, in rats treated with BA 
attenuate abnormalities consisted of asymmetric soft tissue swelling and small erosions, periosteal thickening, and min imal 
joint space narrowing, predominantly localized to the proximal areas of the paws as shown in Figure 4.  
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Figure 4: Effect of Methanolic extract of Bambusa arundinacea on Radiographs of tibiotarsal joints. 
A- Normal Control, B- Disease Control, C- Dexamethasone, 
D- BA 100 mg/kg,    E- BA 200 mg/kg,     F- BA 300 mg/kg 
Despite a similar clin ical course of arthritis, d isease control 
rats suffered from more pronounced bone destruction than 
Bambusa arundinacea treated  animals as seen on 
radiographs taken on day 21
st
 day in complete Freund’s 
adjuvant induce arthritis. BA treated animals had a more 
pronounced decrease in bone density, destruction of bony 
structures, as compare to Disease control as shown in 
Figure 5. Abrogation of disease progression by BA was 
further supported by the histopathologic analysis of the 
joints from these animals. Rats that had been 
prophylactically treated with BA at the time CFA 
immunizat ion showed no histological  abnormalities, with 
no evidence of cartilage erosion in their joints in contrast 
to the diseased control rats that displayed completely  
destroyed joint architecture as shown in Figure 6. CFA-
induced arthritic scores were reduced across all disease 
parameters assessed (inflammation, cartilage damage).  
 
FIGURE 5: Effect of Methanolic extract of Bambusa arundinacea on Radiographic score in Arthritic Rats 
 
 
Figure 6:  Histopathology of joints indicates treatment with Methanolic extract of Bambusa arundinacea prevent bone erosion. 
A- Normal Control , B- Disease Control,  C- Dexamethasone, 
D- BA 100 mg/kg,    E- BA 200 mg/kg,     F- BA 300 mg/kg
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FIGURE 7: Effect of Methanolic extract of Bambusa arundinacea on Spleen index in Arthritic Rats 
The spleen provided a readily available source of cells 
known to be involved in arthritis. Increased cellularity in  
the spleen of arthritic rats engendered interest as to the 
potential for concomitant classical antibody formation. BA 
inhibits splenomegaly, which can enhance inhibitory effect 
of drug as shown in Figure 7. It may be that in vivo BA 
gives the chronic anti-inflammatory effect by suppression 
of splenic lymphocytes, which might then result in reduced 
immunological activation, and subsequent inhibition of the 
infiltrat ion of circulat ing lymphocytes into the synovium.  
CONCLUS ION 
Our data suggested that Bambusa arundinacea possesses 
significant Anti-arthrit ic activity. The possible mode of 
antiarthritic activity of Methanolic extract of Bambusa 
arundinacea  appears to be, Possessing anti–inflammatory  
activity showed in arthritic parameters like Paw edema, 
Arthritic index, Rheumatoid factor, improving bone 
erosion. All these results thus predict that the drug provide 
pharmacological rat ionale for the tradit ional use of the 
drug against inflammatory disorders such as rheumatoid 
arthritis.  
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